Alfred Lim, PhDHead of Early Pipeline Research at Etcembly Ltd.Speaker
Agenda Sessions
Short Oral Poster Presentation 1: A Novel Generative AI-designed T cell Receptor Bispecific for Cancer Immunotherapy
, 5:45pmView Session